Fact CheckerSign in

NCT07785492Recruiting

Artificial Intelligence Support for Stroke

Artificial Intelligence-Assisted Decision Support for Intravenous Thrombolysis in Acute Ischemic Stroke at Basic Hospitals in China (ASSIST)

Source: ClinicalTrials.gov · Last updated 27 Aug 2026

Brief summary (registry, in English)

This study investigates whether an AI-assisted decision support tool, compared with standard care, increases the proportion of acute ischemic stroke patients receiving intravenous thrombolysis within 24 hours of symptom onset at a primary hospital in China, while also evaluating its impact on clinical outcomes, treatment timelines, and safety.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
516 (estimated)
First submitted
15 Aug 2026
Start date
26 Aug 2026
Primary completion date
31 Dec 2026
Lead sponsor
Capital Medical University
Diseases
Stroke
NCT number
NCT07785492

What you commit to

  • Study type: Interventional
  • Planned participants: 516
  • From 26 Aug 2026 to the primary completion date, 31 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Currently participating in another interventional clinical trial related to drugs or devices.
  • Has received intravenous thrombolysis at another hospital.
  • Has completed a definitive reperfusion therapy decision at another hospital and is transferred to this hospital solely for follow-up observation or rehabilitation.

Other

  • Pregnant women.

Who the study is looking for

  • Age ≥18 years.
  • Clinical diagnosis of acute ischemic stroke.
  • Onset time (last known well) \<24 hours.
  • CT or MRI examination excluding intracerebral hemorrhage.
  • Signed informed consent by the patient or a legally authorized representative

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Liuyang Jili Hospital
Coordinator of this site? Confirm its status
ChangshaChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.